Transgenic mouse model for breast cancer: Induction of breast cancer in novel oncogene HCCR-2 transgenic mice

Jesang Ko; Seung Min Shin; Young Mi Oh; Youn Soo Lee; Zae Yoong Ryoo; Young Han Lee; Doe Sun Na; Jin Woo Kim

doi:10.1038/sj.onc.1207356

Transgenic mouse model for breast cancer: Induction of breast cancer in novel oncogene HCCR-2 transgenic mice

Jesang Ko
, Seung Min Shin
, Young Mi Oh
, Youn Soo Lee
, Zae Yoong Ryoo
, Young Han Lee
, Doe Sun Na
, Jin Woo Kim

University of Ulsan
The Catholic University of Korea
Yeungnam University

Research output: Contribution to journal › Article › peer-review

39 Scopus citations

Abstract

Transgenic mice containing novel oncogene HCCR-2 were generated to analyse the phenotype and to characterize the role of HCCR-2 in cellular events. Mice transgenic for HCCR-2 developed breast cancers and metastasis. The level of p53 in HCCR-2 transgenic mice was elevated in most tissues including breast, brain, heart, lung, liver, stomach, kidney, spleen, and lymph node. We examined whether stabilized p53 is functional in HCCR-2 transgenic mice. Defective induction of p53 responsive genes including p21^WAF1, MDM2, and bax indicates that stabilized p53 in HCCR-2 transgenic mice exists in an inactive form. These results suggest that HCCR-2 represents an oncoprotein that is related to breast cancer development and regulation of the p53 tumor suppressor.

Original language	English
Pages (from-to)	1950-1953
Number of pages	4
Journal	Oncogene
Volume	23
Issue number	10
DOIs	https://doi.org/10.1038/sj.onc.1207356
State	Published - 11 Mar 2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Breast cancer
HCCR-2
p53
Transgenic mouse

Access to Document

10.1038/sj.onc.1207356

Cite this

@article{a518aa4438884c648a2bd0e5a5965c56,

title = "Transgenic mouse model for breast cancer: Induction of breast cancer in novel oncogene HCCR-2 transgenic mice",

abstract = "Transgenic mice containing novel oncogene HCCR-2 were generated to analyse the phenotype and to characterize the role of HCCR-2 in cellular events. Mice transgenic for HCCR-2 developed breast cancers and metastasis. The level of p53 in HCCR-2 transgenic mice was elevated in most tissues including breast, brain, heart, lung, liver, stomach, kidney, spleen, and lymph node. We examined whether stabilized p53 is functional in HCCR-2 transgenic mice. Defective induction of p53 responsive genes including p21WAF1, MDM2, and bax indicates that stabilized p53 in HCCR-2 transgenic mice exists in an inactive form. These results suggest that HCCR-2 represents an oncoprotein that is related to breast cancer development and regulation of the p53 tumor suppressor.",

keywords = "Breast cancer, HCCR-2, p53, Transgenic mouse",

author = "Jesang Ko and Shin, \{Seung Min\} and Oh, \{Young Mi\} and Lee, \{Youn Soo\} and Ryoo, \{Zae Yoong\} and Lee, \{Young Han\} and Na, \{Doe Sun\} and Kim, \{Jin Woo\}",

year = "2004",

month = mar,

day = "11",

doi = "10.1038/sj.onc.1207356",

language = "English",

volume = "23",

pages = "1950--1953",

journal = "Oncogene",

issn = "0950-9232",

publisher = "Springer Nature",

number = "10",

}

TY - JOUR

T1 - Transgenic mouse model for breast cancer

T2 - Induction of breast cancer in novel oncogene HCCR-2 transgenic mice

AU - Ko, Jesang

AU - Shin, Seung Min

AU - Oh, Young Mi

AU - Lee, Youn Soo

AU - Ryoo, Zae Yoong

AU - Lee, Young Han

AU - Na, Doe Sun

AU - Kim, Jin Woo

PY - 2004/3/11

Y1 - 2004/3/11

N2 - Transgenic mice containing novel oncogene HCCR-2 were generated to analyse the phenotype and to characterize the role of HCCR-2 in cellular events. Mice transgenic for HCCR-2 developed breast cancers and metastasis. The level of p53 in HCCR-2 transgenic mice was elevated in most tissues including breast, brain, heart, lung, liver, stomach, kidney, spleen, and lymph node. We examined whether stabilized p53 is functional in HCCR-2 transgenic mice. Defective induction of p53 responsive genes including p21WAF1, MDM2, and bax indicates that stabilized p53 in HCCR-2 transgenic mice exists in an inactive form. These results suggest that HCCR-2 represents an oncoprotein that is related to breast cancer development and regulation of the p53 tumor suppressor.

AB - Transgenic mice containing novel oncogene HCCR-2 were generated to analyse the phenotype and to characterize the role of HCCR-2 in cellular events. Mice transgenic for HCCR-2 developed breast cancers and metastasis. The level of p53 in HCCR-2 transgenic mice was elevated in most tissues including breast, brain, heart, lung, liver, stomach, kidney, spleen, and lymph node. We examined whether stabilized p53 is functional in HCCR-2 transgenic mice. Defective induction of p53 responsive genes including p21WAF1, MDM2, and bax indicates that stabilized p53 in HCCR-2 transgenic mice exists in an inactive form. These results suggest that HCCR-2 represents an oncoprotein that is related to breast cancer development and regulation of the p53 tumor suppressor.

KW - Breast cancer

KW - HCCR-2

KW - p53

KW - Transgenic mouse

UR - https://www.scopus.com/pages/publications/1842482281

U2 - 10.1038/sj.onc.1207356

DO - 10.1038/sj.onc.1207356

M3 - Article

C2 - 14691448

AN - SCOPUS:1842482281

SN - 0950-9232

VL - 23

SP - 1950

EP - 1953

JO - Oncogene

JF - Oncogene

IS - 10

ER -

Transgenic mouse model for breast cancer: Induction of breast cancer in novel oncogene HCCR-2 transgenic mice

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this